Servier Canada

Focus: Oncology – Brain tumors, Diffuse gliomas, Isocitrate dehydrogenase (IDH)–mutant cancers

Servier is a global pharmaceutical group (21,900 employees), governed by a Foundation. Our independence allows the freedom to pursue our vocation: our commitment to therapeutic progress to serve patient needs.

Pharmaceutical Companies